Matecka D - Search Results

1

Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.

Matecka D, Lewis D, Rothman RB, Dersch CM, Wojnicki FH, Glowa JR, DeVries AC, Pert A, Rice KC. Matecka D, et al. J Med Chem. 1997 Feb 28;40(5):705-16. doi: 10.1021/jm9606599. J Med Chem. 1997. PMID: 9057857

2

DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methods.

Gilbert KM, Boos TL, Dersch CM, Greiner E, Jacobson AE, Lewis D, Matecka D, Prisinzano TE, Zhang Y, Rothman RB, Rice KC, Venanzi CA. Gilbert KM, et al. Among authors: matecka d. Bioorg Med Chem. 2007 Jan 15;15(2):1146-59. doi: 10.1016/j.bmc.2006.09.070. Epub 2006 Oct 1. Bioorg Med Chem. 2007. PMID: 17127069 Free PMC article.

3

Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate, a long-acting ester derivative of GBR 12909.

Glowa JR, Fantegrossi WE, Lewis DB, Matecka D, Rice KC, Rothman RB. Glowa JR, et al. Among authors: matecka d. J Med Chem. 1996 Nov 22;39(24):4689-91. doi: 10.1021/jm960551t. J Med Chem. 1996. PMID: 8941381 No abstract available.

4

Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).

Matecka D, Rothman RB, Radesca L, de Costa BR, Dersch CM, Partilla JS, Pert A, Glowa JR, Wojnicki FH, Rice KC. Matecka D, et al. J Med Chem. 1996 Nov 22;39(24):4704-16. doi: 10.1021/jm960305h. J Med Chem. 1996. PMID: 8941383

5

Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents.

Lewis DB, Matecka D, Zhang Y, Hsin LW, Dersch CM, Stafford D, Glowa JR, Rothman RB, Rice KC. Lewis DB, et al. Among authors: matecka d. J Med Chem. 1999 Dec 2;42(24):5029-42. doi: 10.1021/jm990291q. J Med Chem. 1999. PMID: 10585212

6

Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.

Rothman RB, Silverthorn ML, Baumann MH, Goodman CB, Cadet JL, Matecka D, Rice KC, Carroll FI, Wang JB, Uhl GR, et al. Rothman RB, et al. Among authors: matecka d. J Pharmacol Exp Ther. 1995 Jul;274(1):385-95. J Pharmacol Exp Ther. 1995. PMID: 7616423

7

Cocaine cross-sensitization to dopamine uptake inhibitors: unique effects of GBR12909.

Elmer GI, Brockington A, Gorelick DA, Carrol FI, Rice KC, Matecka D, Goldberg SR, Rothman RB. Elmer GI, et al. Among authors: matecka d. Pharmacol Biochem Behav. 1996 Apr;53(4):911-8. doi: 10.1016/0091-3057(95)02143-4. Pharmacol Biochem Behav. 1996. PMID: 8801597

8

Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys.

Glowa JR, Rice KC, Matecka D, Rothman RB. Glowa JR, et al. Among authors: matecka d. Neuroreport. 1997 Apr 14;8(6):1347-51. doi: 10.1097/00001756-199704140-00006. Neuroreport. 1997. PMID: 9172133

9

Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.

Rothman RB, Silverthorn ML, Glowa JR, Matecka D, Rice KC, Carroll FI, Partilla JS, Uhl GR, Vandenbergh DJ, Dersch CM. Rothman RB, et al. Among authors: matecka d. Synapse. 1998 Apr;28(4):322-38. doi: 10.1002/(SICI)1098-2396(199804)28:4<322::AID-SYN8>3.0.CO;2-B. Synapse. 1998. PMID: 9517841

10

Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.

Villemagne VL, Rothman RB, Yokoi F, Rice KC, Matecka D, Dannals RF, Wong DF. Villemagne VL, et al. Among authors: matecka d. Synapse. 1999 Apr;32(1):44-50. doi: 10.1002/(SICI)1098-2396(199904)32:1<44::AID-SYN6>3.0.CO;2-9. Synapse. 1999. PMID: 10188637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page